Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- A2436 Fluoxetine HClTarget: Serotonin (5-HT) reuptakeSummary: Serotonin reuptake inhibitor,selective
- A2553 Fluvoxamine maleateSummary: Serotonin reuptake inhibitor,selective,antidepressant
- A2890 NepafenacSummary: COX-1 and COX-2 inhibitor
- A1607 PrasugrelSummary: ADP receptor inhibitor
- A1366 Rocuronium BromideSummary: TGF-βR I kinase inhibitor
- A1684 AprepitantTarget: Substance P/NK1 ReceptorSummary: Substance P (SP) inhibitor
- A1745 Galanthamine HBrSummary: Acetylcholinesterase inhibitor
- A5166 Ondansetron HClTarget: 5-HT3 ReceptorsSummary: 5-HT3 receptor antagonist
- A5355 VenlafaxineSummary: Dual serotonin/noradrenalin re-uptake inhibitor
- A5322 Tianeptine sodiumSummary: 5-HT uptake facilitator,selective,antidepressant